The Difficulties of Cloning a CEO - Bloomberg
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says | Ctech
TEVA: Teva Pharmaceutical Industries Ltd Stock Price Quote - New York - Bloomberg
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Glaxo's Win in Case Against Teva Lifts Other Drugmakers - Bloomberg
Teva 'Skinny Label' Ruling Comes Amid Lawmaker Drug Cost Fight - Bloomberg Law
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
Watch Mylan Board Rejects $40.1B Teva Takeover Bid - Bloomberg
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva, Allergan ready to pay $5B to settle thousands of opioid lawsuits (TEVA) | Seeking Alpha
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Teva's U.S. Unit Charged in Generic-Drug Price-Fixing Probe
Teva, Some Units Fueled Opioid Crisis, N.Y. Jury Concludes (2)
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion
Teva Pharmaeutical Stock Gets Upgrade From Analyst | Barron's
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva Is Exploring Mylan Bid to Create Generic-Drug Giant - Bloomberg
Teva sees close of $40.5B Allergan generics deal by June - BNN Bloomberg
Israel's Teva offering free drugs to settle U.S. opiods case - Business - Haaretz.com
